Religare Enterprises Limited (REL) announced its audited financial results for the quarter and year ended March 31, 2026, during a board meeting held on May 12, 2026. The company reported a consolidated total income of ₹2,154.21 Crores for the quarter ended March 31, 2026, representing a growth of 4.37% compared to ₹2,063.92 Crores in the previous quarter ended December 31, 2025. On a year-on-year (YoY) basis, revenue surged by 25.98% from ₹1,709.95 Crores in the corresponding quarter of the previous year. The company posted a net profit of ₹95.65 Crores for the current quarter, a significant turnaround from a net loss of ₹76.54 Crores in the previous quarter. Compared to the same period last year, profit increased by 3.65% from ₹92.28 Crores.

Religare Enterprises Limited is a diversified financial services holding company operating across health insurance, retail broking, and specialized lending through its subsidiaries like Care Health Insurance and Religare Finvest. In early 2025, the company underwent a major leadership transition as the Burman family, promoters of Dabur India, officially assumed the role of promoters after acquiring a controlling 25.16% stake. Significant developments in 2025 included the Reserve Bank of India (RBI) removing the Corrective Action Plan (CAP) on Religare Finvest in July 2025, allowing it to restart its SME lending business. The company also announced a strategic demerger plan in February 2026 to unlock value by separating its health insurance and financial services arms. Prominent institutional investors and the Burman family remain the key stakeholders driving the company’s “Religare 2.0” growth strategy.